Child Sexual Abuse Assault and Battery Burglary Capital Offenses Civil Forfeiture Crime Victims Compensation Criminal Appeals Criminal Conspiracy Criminal Defense Criminal Forfeiture Criminal Fraud Criminal Investigation Death Penalty Domestic Violence Drivers License Suspension Driving While Intoxicated Electronic Surveillance DUI/DWI Expungements Extortion Extradition Federal Criminal Law Felonies Forgery Hit and Run White Collar Fraud Homicide Manslaughter Misdemeanors Money Laundering Murder Parole and Probation Search and Seizure Sex Crimes Sexual Assault Shoplifting Stalking Theft Traffic Violations Vehicular Homicide Weapons Charges Civil Drug Forfeiture Controlled Substances Drug Crimes Drug Forfeiture Drug Trafficking Intentional Torts Tort Liability Embezzlement White Collar Criminal Defense Criminal Law - Defense Tort & Personal Injury Car Accidents
ISLN:
913745838
Admitted:
1994
University:
Rhodes College, B.A., 1989
Law School:
Tulane Univesity, J.D., 1994
Medicine Doctors
Dr. James L Gulley, Bethesda MD - MD (Doctor of Medicine)
NIH Clinical Center 10 Center Drive, Bethesda, MD 20892
Procedures:
Prostate Cancer
Conditions:
Prostate Cancer
Certifications:
Internal Medicine, 1999 Medical Oncology, 2010
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School Loma Linda University School Of Medicine Graduated: 1995 Medical School Emory University School Of Med Graduated: 1998 Medical School National Canc Institute Graduated: 2000
Loma Linda University, School of Medicine - Doctor of Medicine Loma Linda University - Doctor of Philosophy National Institutes of Health-Clinical Center - Fellowship - Oncology (Internal Medicine)
Board certifications:
American Board of Internal Medicine Sub-certificate in Oncology (Internal Medicine)
Us Patents
Biomarkers For Prostate Cancer And Methods For Their Detection
Jeffrey Gildersleeve - Frederick MD, US Christopher Campbell - Baltimore MD, US Oyindasola Oyelaran - Boston MA, US James Gulley - Takoma Park MD, US Jeffrey Schlom - Potomac MD, US
International Classification:
A61K 39/00
US Classification:
4242771, 435 792, 536 111, 530395
Abstract:
The invention provides a method for predicting the clinical response to a cancer vaccine in a patient having cancer, a method for determining the immune response to a cancer vaccine in a patient having cancer who has been administered a cancer vaccine, a method for determining the long-term survival in a patient having cancer, corresponding kits therefor, as well as methods of for improving the efficacy of a virus-based vaccine.
A tool carrier has a frame formed from a closed wire loop which includes a tool insertion portion having spaced side rail members connected by an arcuate end bar. An attachment portion of the frame has spaced attachment rail members each connected by a ninety degree bend with one of said side rail members. A clip portion of the frame includes a pair of spaced clip members connected by an arcuate connecting bar, with each of clip members connected by a 180 degree bend with one of the attachment rail members to form a resilient frictional clip for securement to an article of apparel of an individual. A variety of different removable receptacles are disclosed for removable securement in the tool insertion portion of the frame. The various receptacles may be utilized to carry small articles, scissors, and a variety of other tools. The tool carrier frame is dimensioned to receive a conventional hammer with the receptacle removed from the tool insertion portion.
Combination Pdl1 And Tgf-Beta Blockade In Patients With Hpv+ Malignancies
The invention provides a method of inhibiting a malignancy associated with human papilloma virus (HPV) comprising administering to a subject an agent that blocks PD-L1 and TGF-beta pathways, thereby inhibiting a malignancy associated with HPV in the subject.
Biomarkers For Prostate Cancer And Methods For Their Detection
- Bethesda MD, US Christopher Campbell - Baltimore MD, US Oyindasola Oyelaran - Boston MA, US James Gulley - Takoma Park MD, US Jeffrey Schlom - Potomac MD, US
Assignee:
The United States of America, as represented by the Secretary, Department of Health and Human Serv - Bethesda MD
International Classification:
G01N 33/574 A61K 39/00
Abstract:
The invention provides a method for predicting the clinical response to a cancer vaccine in a patient having cancer, a method for determining the immune response to a cancer vaccine in a patient having cancer who has been administered a cancer vaccine, a method for determining the long-term survival in a patient having cancer, corresponding kits therefor, as well as methods of for improving the efficacy of a virus-based vaccine.
License Records
James R. Gulley Jr.
License #:
PIC.020650 - Active
Issued Date:
Jul 23, 2014
Expiration Date:
Dec 31, 2017
Type:
Pharmacist-in-Charge (V)
James R. Gulley Jr.
License #:
PNT.045456 - Expired
Issued Date:
Jul 9, 2007
Expiration Date:
Jul 9, 2012
Type:
Pharmacy Intern
James R. Gulley Jr.
License #:
PST.020650 - Active
Issued Date:
Jul 23, 2014
Expiration Date:
Dec 31, 2017
Type:
Pharmacist
James G. Gulley
License #:
13976 - Expired
Category:
None on File
Type:
Retired
Name / Title
Company / Classification
Phones & Addresses
James Gulley Chairman
Sligo Seventh Day Adventist Church Religious Organization
Leadership Management Microsoft Word Powerpoint Research Marketing Microsoft Excel Social Media Public Speaking Training Process Improvement Customer Service Sales
Were getting something to work. Now we need to get it to work better, said Dr. James Gulley, who helps lead a center at the National Cancer Institute that develops immune therapies, including cancer treatment vaccines.
vaccine, we can clearly generate immune responses that lead to clinical responses in some patients," lead scientist Dr. James Gulley, director and deputy chief of the clinical trials group at the laboratory of tumor immunology and biology at the National Cancer Institute, said in a written statement.
Date: Nov 09, 2011
Category: Health
Source: Google
Experimental Vaccine to Treat Breast, Ovarian Cancer Shows Promise
The difference is that the shot would treat, rather than prevent, cancer. Dr. James Gulley and his colleagues report on the strategy called immunotherapy in the journal Clinical Cancer Research.
Date: Nov 08, 2011
Source: Google
Googleplus
James Gulley
Work:
Xerox Services - Senior Financial Analyst (2009) MGM Grand Detroit - Dealer (2008-2009) Chrysler Group LLC - Financial Analyst (2004-2008) WorldTravel BTI - Staff Accountant (2001-2004) Arthur Andersen - Staff Accountant (1999-2001) Amtec Precision Products - Accounts Payable Specialist (1998-1999) United States Army - Staff Sergeant (1991-1998)
Education:
Walsh College of Business & Accountancy - MBA - Finance, University of Phoenix - Accounting
Relationship:
Married
James Gulley
Lived:
Takoma Park, MD
Work:
National Cancer Institute - Director, Clinical Trials Group
James Gulley
About:
Firm founder James M. Gulley has been a presence in the Shelby County court system for over 15 years, and has an established and respected reputation in the Memphis legal community. He appears in cour...